Search details
1.
Oncometabolites suppress DNA repair by disrupting local chromatin signalling.
Nature
; 582(7813): 586-591, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32494005
2.
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial.
Lancet
; 401(10379): 821-832, 2023 03 11.
Article
in English
| MEDLINE | ID: mdl-36774933
3.
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet
; 402(10407): 1043-1051, 2023 09 23.
Article
in English
| MEDLINE | ID: mdl-37524096
4.
Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.
Cancer Invest
; 42(1): 97-103, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38314786
5.
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
J Natl Compr Canc Netw
; 22(1): 4-16, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38394781
6.
The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy.
BMC Urol
; 24(1): 102, 2024 May 03.
Article
in English
| MEDLINE | ID: mdl-38702664
7.
Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma.
Eur Radiol
; 33(3): 1801-1811, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36329348
8.
Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing.
Cancer
; 128(4): 675-684, 2022 02 15.
Article
in English
| MEDLINE | ID: mdl-34724198
9.
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.
Lancet
; 397(10275): 695-703, 2021 02 20.
Article
in English
| MEDLINE | ID: mdl-33592176
10.
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(1): 71-90, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34991070
11.
CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells.
Molecules
; 27(23)2022 Dec 02.
Article
in English
| MEDLINE | ID: mdl-36500549
12.
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Cancer
; 127(21): 3957-3966, 2021 Nov 01.
Article
in English
| MEDLINE | ID: mdl-34343338
13.
Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective.
Radiographics
; 41(5): 1387-1407, 2021.
Article
in English
| MEDLINE | ID: mdl-34270355
14.
Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer.
Cancer
; 126(16): 3657-3666, 2020 08 15.
Article
in English
| MEDLINE | ID: mdl-32413184
15.
Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
Cancer Causes Control
; 31(1): 85-93, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31782041
16.
The Role of Opioids and Their Receptors in Urological Malignancy: A Review.
J Urol
; 204(6): 1150-1159, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32516030
17.
Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial.
J Urol
; 204(3): 531-537, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32250730
18.
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
J Natl Compr Canc Netw
; 18(9): 1160-1170, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32886895
19.
Analysis of guideline recommended use of renal mass biopsy and association with treatment.
Can J Urol
; 27(4): 10285-10293, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32861253
20.
Whole-genome analysis of papillary kidney cancer finds significant noncoding alterations.
PLoS Genet
; 13(3): e1006685, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28358873